Alexander Marx Selected Research

eltrombopag

1/2022

Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Marx Research Topics

Disease

70	Neoplasms (Cancer) 02/2024 - 01/2002
42	Thymoma (Thymic Carcinoma) 01/2024 - 07/2002
24	Myasthenia Gravis 01/2023 - 07/2002
15	Neoplasm Metastasis (Metastasis) 07/2021 - 05/2007
8	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 10/2016
7	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 09/2007
7	Rhabdomyosarcoma 01/2018 - 01/2006
4	Thymus Neoplasms (Thymus Neoplasm) 09/2021 - 10/2010
4	Carcinoma (Carcinomatosis) 07/2021 - 02/2016
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2009
4	Inflammation (Inflammations) 01/2018 - 01/2008
4	Chorioamnionitis 04/2009 - 02/2005
3	Lymphoma (Lymphomas) 01/2024 - 09/2005
3	Disease Progression 01/2023 - 01/2002
3	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 05/2007
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2021 - 05/2007
3	Infections 02/2019 - 01/2008
3	Adenocarcinoma 10/2018 - 08/2011
2	Carcinogenesis 02/2024 - 08/2011
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2023 - 07/2021
2	Teratoma (Teratoid Tumor) 05/2023 - 01/2022
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2022
2	Microsatellite Instability 12/2021 - 01/2019
2	Hyperplasia 10/2021 - 12/2012
2	Autoimmune Diseases (Autoimmune Disease) 12/2018 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017 - 01/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2014 - 01/2003
2	Hepatocellular Carcinoma (Hepatoma) 10/2013 - 03/2013
2	Atherosclerosis 10/2009 - 07/2006
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 02/2024
1	Wounds and Injuries (Trauma) 09/2023

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 10/2023 - 05/2007
21	Cholinergic ReceptorsIBA 01/2023 - 03/2005
12	AutoantibodiesIBA 02/2019 - 01/2006
10	Biomarkers (Surrogate Marker)IBA 11/2022 - 08/2013
8	Messenger RNA (mRNA)IBA 11/2022 - 09/2008
6	AntibodiesIBA 10/2021 - 03/2005
5	Imatinib Mesylate (Gleevec)FDA Link 02/2021 - 06/2004
5	Prednisone (Sone)FDA LinkGeneric 01/2019 - 12/2012
5	Phosphotransferases (Kinase)IBA 01/2016 - 03/2005
4	ParaffinIBA 10/2023 - 01/2009
4	AntigensIBA 08/2020 - 09/2008
4	CytokinesIBA 01/2020 - 07/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 09/2005
4	margatoxinIBA 01/2019 - 12/2012
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2010 - 01/2008
3	RNA (Ribonucleic Acid)IBA 05/2023 - 06/2002
3	Sunitinib (Sutent)FDA Link 09/2022 - 10/2010
3	Immune Checkpoint InhibitorsIBA 12/2021 - 10/2017
3	MicroRNAs (MicroRNA)IBA 07/2021 - 01/2018
3	Insulin-Like PeptidesIBA 01/2018 - 09/2007
3	Urokinase Plasminogen Activator ReceptorsIBA 05/2010 - 01/2009
3	Ribonucleases (Ribonuclease)IBA 09/2008 - 06/2002
2	Transcription Factors (Transcription Factor)IBA 02/2024 - 01/2015
2	Phenobarbital (Luminal)FDA Link 05/2023 - 01/2017
2	Tissue ExtractsIBA 05/2023 - 01/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2022 - 09/2005
2	LigandsIBA 01/2022 - 05/2016
2	Keratins (Keratin)IBA 01/2022 - 09/2014
2	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 01/2014
2	Monoclonal AntibodiesIBA 01/2020 - 10/2017
2	CateninsIBA 01/2019 - 01/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 05/2014
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 05/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2014
2	Indicators and Reagents (Reagents)IBA 10/2017 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2017 - 01/2008
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2017 - 09/2005
2	SteroidsIBA 12/2015 - 01/2011
2	PlakophilinsIBA 12/2015 - 09/2013
2	Glucose (Dextrose)FDA LinkGeneric 12/2015 - 05/2007
2	muskIBA 01/2015 - 03/2005
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 02/2005
2	Formaldehyde (Formol)FDA Link 12/2014 - 01/2009
2	SurvivinIBA 01/2014 - 06/2013
2	Sorafenib (BAY 43-9006)FDA Link 10/2013 - 10/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2012 - 01/2008
2	ChemokinesIBA 08/2011 - 09/2005
2	Serine Proteases (Serine Protease)IBA 05/2010 - 06/2009
2	Apolipoproteins E (ApoE)IBA 10/2009 - 07/2006
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2009 - 05/2007
2	Protein Isoforms (Isoforms)IBA 09/2007 - 06/2002
2	Immunoglobulins (Immunoglobulin)IBA 09/2005 - 11/2004
1	Untranslated RNA (Noncoding RNA)IBA 02/2024
1	Capsules (Microcapsules)IBA 01/2024
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 10/2023
1	Carrier Proteins (Binding Protein)IBA 10/2023

Therapy/Procedure

28	Therapeutics 01/2023 - 07/2002
13	Drug Therapy (Chemotherapy) 01/2024 - 07/2002
9	Thymectomy 01/2023 - 03/2003
6	Immunotherapy 01/2019 - 02/2013
3	Lasers (Laser) 01/2019 - 01/2009
2	Neoadjuvant Therapy 01/2016 - 01/2014
2	Adjuvant Radiotherapy 12/2012 - 04/2004
2	Radiotherapy 09/2009 - 01/2004
2	Aftercare (After-Treatment) 09/2009 - 08/2003
2	Adjuvant Chemoradiotherapy 04/2004 - 07/2002
1	Combined Modality Therapy 02/2024
1	Surgical Instruments (Clip) 09/2023